Agree Quanta, what makes it better is that it is a small team, the CEO owns 10%. Without ramping could it go down similar pathways to BAL and BKL?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025